Literature DB >> 14766365

Blood vessels and parkinsonism.

Carlos Barcia1, Marina E Emborg, Etienne C Hirsch, María-Trinidad Herrero.   

Abstract

Blood vessels are the way for nutrients present outside the brain to gain access into the cerebral parenchyma. When neurons are diseased, for example by toxin exposure, reactive glial cells secrete local factors that induce microangiogenesis, probably as part of a spontaneous neuroprotective mechanism related to the increased metabolic demand. In Parkinson's disease (PD) and non human primate models of PD, nigral degeneration is associated with gliosis and microvascular proliferation. Interestingly, microangiogenesis also facilitates the entrance into the brain parenchyma of neurotoxins and harmful cytokine-releasing blood cells, both of which have been linked to neuronal cell death in PD. In the present review we discuss the potential implications of vascular-related phenomena with mechanisms of neuronal damage in PD.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14766365     DOI: 10.2741/1145

Source DB:  PubMed          Journal:  Front Biosci        ISSN: 1093-4715


  11 in total

1.  An angiogenic inhibitor, cyclic RGDfV, attenuates MPTP-induced dopamine neuron toxicity.

Authors:  Aditiben Patel; Giuseppe V Toia; Kalea Colletta; Brinda Desai Bradaric; Paul M Carvey; Bill Hendey
Journal:  Exp Neurol       Date:  2011-06-15       Impact factor: 5.330

2.  Degeneration and repair in central nervous system disease.

Authors:  Eng H Lo
Journal:  Nat Med       Date:  2010-09-21       Impact factor: 53.440

3.  Evidence for angiogenesis in Parkinson's disease, incidental Lewy body disease, and progressive supranuclear palsy.

Authors:  Brinda Desai Bradaric; Aditiben Patel; Julie A Schneider; Paul M Carvey; Bill Hendey
Journal:  J Neural Transm (Vienna)       Date:  2011-07-12       Impact factor: 3.575

4.  TNF-alpha knockout and minocycline treatment attenuates blood-brain barrier leakage in MPTP-treated mice.

Authors:  Chaohui Zhao; Zaodung Ling; Mary B Newman; Ankush Bhatia; Paul M Carvey
Journal:  Neurobiol Dis       Date:  2007-01-17       Impact factor: 5.996

5.  Antioxidant or neurotrophic factor treatment preserves function in a mouse model of neovascularization-associated oxidative stress.

Authors:  Michael I Dorrell; Edith Aguilar; Ruth Jacobson; Oscar Yanes; Ray Gariano; John Heckenlively; Eyal Banin; G Anthony Ramirez; Mehdi Gasmi; Alan Bird; Gary Siuzdak; Martin Friedlander
Journal:  J Clin Invest       Date:  2009-02-02       Impact factor: 14.808

Review 6.  The blood-brain barrier in neurodegenerative disease: a rhetorical perspective.

Authors:  Paul M Carvey; Bill Hendey; Angela J Monahan
Journal:  J Neurochem       Date:  2009-07-31       Impact factor: 5.372

Review 7.  Neurovascular abnormalities in brain disorders: highlights with angiogenesis and magnetic resonance imaging studies.

Authors:  Chiao-Chi V Chen; Yu-Chen Chen; Han-Yun Hsiao; Chen Chang; Yijuang Chern
Journal:  J Biomed Sci       Date:  2013-07-05       Impact factor: 8.410

8.  Systemic administration of 6-OHDA to rhesus monkeys upregulates HLA-DR expression in brain microvasculature.

Authors:  Valerie Joers; Scott Vermilyea; Kristine Dilley; Marina E Emborg
Journal:  J Inflamm Res       Date:  2014-09-18

9.  Vascular Inflammation Is a Risk Factor Associated with Brain Atrophy and Disease Severity in Parkinson's Disease: A Case-Control Study.

Authors:  Chiun-Chieh Yu; Hsiu-Ling Chen; Meng-Hsiang Chen; Cheng-Hsien Lu; Nai-Wen Tsai; Chih-Cheng Huang; Yung-Yee Chang; Shau-Hsuan Li; Yueh-Sheng Chen; Pi-Ling Chiang; Wei-Che Lin
Journal:  Oxid Med Cell Longev       Date:  2020-07-14       Impact factor: 6.543

10.  Correcting Differential Gene Expression Analysis for Cyto-Architectural Alterations in Substantia Nigra of Parkinson's Disease Patients Reveals Known and Potential Novel Disease-Associated Genes and Pathways.

Authors:  Federico Ferraro; Christina Fevga; Vincenzo Bonifati; Wim Mandemakers; Ahmed Mahfouz; Marcel Reinders
Journal:  Cells       Date:  2022-01-07       Impact factor: 6.600

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.